Pay in 4 interest-free payments of $7.18 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
What the Research Says About Safety Clinical studies on AOD9604 indicate that the peptide is generally welltolerated: In human trials, no significant adverse effects were reported at doses up to 1 mg/day (safety summary) Unlike growth hormone therapies, AOD9604 does not meaningfully elevate IGF1 levels (human data), which may reduce the risk of unwanted growthrelated side effects
2013 (PMID 23055539), which carries a 2021 Expression of Concern
Barton W, Penney NC, Cronin O, Garcia-Perez I, Molloy MG, Holmes E, Shanahan F, Cotter PD, Osullivan O
2009 Apr;301(4):301-6
Domain I helices are shown in dark blue and beta strands are shown in red
US$ 24.35
US$ 24.47
.png.jpg)
US$ 27.51
US$ 24.64
US$ 23.58
US$ 20.90
